|
M.Z. Gasanov, M.G. Panchenko, M.M. Batyushin, N.A. Bronovitskaya, A.V. Razina
Endothelial dysfunction in patients with chronic kidney disease: prognostic potential of endothelin-1
|
№4 / 2021
|
|
M.S. Shamkhalova, I.A. Sklyanik, M.V. Shestakova
Beyond glycemic control: nephroprotective effects of glucagon-like peptide 1 receptor agonists
|
№3 / 2021
|
|
Z.D. Mikhailova, V.V. Cherepanova
Thrombocytosis as a cause of thrombohemorrhagic complications in the practice of a nephrologiste
|
№3 / 2021
|
|
I.T. Murkamilov, K.A. Aitbaev, V.V. Fomin, Zh.A. Murkamilova, F.A. Yusupov, I.O. Kudaibergenova
Homocystein and folic acid in chronic kidney disease: clinical and predictive significance
|
№3 / 2021
|
|
M.N. Kolomyitseva, M.Z. Gasanov, M.M. Batyushin, O.M. Manukyan, L.I. Rudenko
Peculiarities of vascular remodeling in patients with chronic kidney disease stage 5D: prognostic role of the intima-media thickness
|
№3 / 2021
|
|
A.M. Essaian, G.P. Arutyunov, O.G. Melikhov
Prevalence of chronic kidney disease in primary care patients. results of a prospective observational study in 12 regions of Russia
|
№3 / 2021
|
|
E.V. Efremova, A.M. Shutov, A.D. Semenov, K.O. Volkova, A.A. Samoshilova
Possibilities of a patient-oriented approach in elderly and senile patients with chronic kidney disease
|
№2 / 2021
|
|
M.Z. Gasanov, V.M. Negoda, M.M. Batyushin
The role of oxidative stress in the development of protein-energy wasting and sarcopenia in patients with stage 5D chronic kidney disease
|
№2 / 2021
|
|
D.V. Fadin, V.A. Fedin, B.V. Zingerman, O.N., Kotenko, I.G. Kargalskaya
The results of 5-year experience in testing the glomerular filtration rate by the INVITRO laboratory in the territory of the Russian Federation
|
№2 / 2021
|
|
S.I. Rey, N.V. Vasina, G.A. Berdnikov, L.V. Marchenkova, O. N. Kotenko
Organization of renal replacement therapy in emergency medicine in the context of new Coronaviral infection
|
№2 / 2021
|
|
A.M. Esayan, A.R. Rind
The role of patient’s adherence in the treatment of hyperphosphatemia in chronic kidney disease
|
№2 / 2020
|
|
G.V. Volgina, N.A. Mikhailovа
Ethelcalcetide in the treatment of secondary hyperparathyroidism in hemodialysis patients: a review of clinical data and a place in therapy
|
№2 / 2020
|
Русский
